Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05249634
PHASE2
Testosterone Treatment in Men with Chronic Kidney Disease
Sponsor: St. Louis University
View on ClinicalTrials.gov
Summary
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
Official title: Effect of JATENZO® Therapy on Testosterone and Hemoglobin Concentrations in Hypogonadal Men with Chronic Kidney Disease
Key Details
Gender
MALE
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2022-03-15
Completion Date
2028-12
Last Updated
2025-03-30
Healthy Volunteers
No
Interventions
DRUG
Jatenzo Pill
oral tablet daily
Locations (1)
Saint Louis Univeristy
St Louis, Missouri, United States